Tajikistan Tech Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tajikistan Tech Daily.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on November 24, 2025

November 24, 2025

SEALSQ Appoints Dr. Ballester Lafuente as Chief of Staff and Group AI Officer

GlobeNewswire

November 24, 2025

Day One Announces Three Year Follow-Up Data From OJEMDA™ (tovorafenib) Phase 2 FIREFLY-1 Trial at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting

GlobeNewswire

November 24, 2025

Chemomab to Participate in Oppenheimer’s Movers in Rare Disease Summit

GlobeNewswire

November 24, 2025

American Rebel Holdings, Inc. (NASDAQ: AREB) Receives Nasdaq Panel Determination Confirming Compliance with Minimum Stockholders’ Equity Requirement

GlobeNewswire

November 24, 2025

LINK FOREX presents an innovative “investment as a side hustle” model to redefine global financial equity

GlobeNewswire

November 24, 2025

Bitcoin Bancorp Reports Improved Revenues for Q3 2025 and Provides Positive Industry and 2026 Outlook

GlobeNewswire

November 24, 2025

Enlivex Announces $212,000,000 Private Placement to Initiate World’s First Prediction Markets Digital Asset Treasury Strategy, via RAIN token Accumulation, and the Appointment of Matteo Renzi, Former Prime Minister of Italy, to its Board

GlobeNewswire

November 24, 2025

Alien™ and Predator™ Invade ‘RAID: Shadow Legends’ for Limited-Time Collaboration

GlobeNewswire

November 24, 2025

Vertero Initiates Phase 1 Study of VT-5006, A Selective Small Molecule Therapy for Parkinson’s Disease

GlobeNewswire

November 24, 2025

Landmark CREST-2 Study Published in the New England Journal of Medicine Highlights the Benefits of Carotid Artery Stenting

GlobeNewswire

November 24, 2025

Plus Therapeutics Announces Completion of U.S. FDA Meeting on Future Clinical Development Plans for REYOBIQ™ in Leptomeningeal Metastases

GlobeNewswire

November 24, 2025

Biogen and Dayra Therapeutics Announce Research Collaboration to Discover and Develop Oral Macrocyclic Peptides for a Range of Immunological Conditions

GlobeNewswire

November 24, 2025

Adaptive Biotechnologies Announces Nearly 90 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 67th ASH Annual Meeting

GlobeNewswire

November 24, 2025

Clearside Biomedical to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process

GlobeNewswire

November 24, 2025

Invivyd Announces Selection of Potential Best-In-Class RSV Antibody Candidate VBY329; Targeting 2H 2026 IND Readiness

GlobeNewswire

November 24, 2025

Harrow to Present at Two Investor Conferences in December

GlobeNewswire

November 24, 2025

Boundless Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference

GlobeNewswire

November 24, 2025

Aquestive Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference

GlobeNewswire

November 24, 2025

Dianthus Therapeutics To Participate in the 8th Annual Evercore Healthcare Conference

GlobeNewswire

November 24, 2025

Arvinas Announces Data Presentations from the Vepdegestrant (ARV-471) Clinical Development Program at the 2025 San Antonio Breast Cancer Symposium (SABCS)

GlobeNewswire